Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hematopoietic Stem Cells | 22 | 2015 | 3385 | 1.680 |
Why?
|
Genes, Immunoglobulin | 17 | 2000 | 291 | 1.510 |
Why?
|
B-Lymphocytes | 29 | 2013 | 4665 | 1.500 |
Why?
|
Chemokines, CXC | 10 | 2007 | 422 | 1.410 |
Why?
|
Immunoglobulin Variable Region | 15 | 1999 | 421 | 1.250 |
Why?
|
Focal Adhesion Kinase 1 | 5 | 2012 | 120 | 1.250 |
Why?
|
Stem Cell Niche | 4 | 2017 | 346 | 1.100 |
Why?
|
Immunoglobulin Heavy Chains | 15 | 2000 | 659 | 1.040 |
Why?
|
Lymphopoiesis | 3 | 2012 | 135 | 0.910 |
Why?
|
Hematopoiesis | 12 | 2020 | 2069 | 0.870 |
Why?
|
Bone Marrow | 11 | 2020 | 2944 | 0.850 |
Why?
|
Agglutinins | 13 | 1995 | 29 | 0.830 |
Why?
|
Focal Adhesion Protein-Tyrosine Kinases | 5 | 2009 | 182 | 0.810 |
Why?
|
Anemia, Hemolytic, Autoimmune | 14 | 1995 | 142 | 0.770 |
Why?
|
Chemotaxis | 8 | 2016 | 607 | 0.740 |
Why?
|
Receptors, CXCR4 | 6 | 2007 | 726 | 0.590 |
Why?
|
Blood Transfusion | 7 | 2020 | 1296 | 0.580 |
Why?
|
Autoantibodies | 15 | 2000 | 2038 | 0.560 |
Why?
|
Rh-Hr Blood-Group System | 9 | 2018 | 65 | 0.520 |
Why?
|
Cell Adhesion | 9 | 2009 | 3144 | 0.500 |
Why?
|
Gene Rearrangement, B-Lymphocyte, Heavy Chain | 6 | 1999 | 92 | 0.480 |
Why?
|
Platelet Transfusion | 3 | 2016 | 314 | 0.470 |
Why?
|
Erythrocytes | 9 | 2018 | 2454 | 0.470 |
Why?
|
Receptors, Chemokine | 3 | 2006 | 669 | 0.470 |
Why?
|
Kell Blood-Group System | 1 | 2013 | 22 | 0.470 |
Why?
|
Chemokine CXCL12 | 11 | 2015 | 464 | 0.470 |
Why?
|
Neutrophils | 10 | 2021 | 3717 | 0.450 |
Why?
|
Isoantibodies | 3 | 2013 | 681 | 0.440 |
Why?
|
Arterioles | 1 | 2013 | 254 | 0.440 |
Why?
|
Bone Marrow Cells | 8 | 2017 | 2513 | 0.440 |
Why?
|
Lymphoma, AIDS-Related | 3 | 2000 | 84 | 0.440 |
Why?
|
Mesenchymal Stem Cells | 5 | 2017 | 1628 | 0.430 |
Why?
|
B-Lymphocyte Subsets | 2 | 2005 | 246 | 0.430 |
Why?
|
Anemia, Hemolytic | 1 | 2013 | 168 | 0.420 |
Why?
|
Immunoglobulin M | 11 | 2006 | 1538 | 0.410 |
Why?
|
Granulocyte Colony-Stimulating Factor | 6 | 2021 | 648 | 0.400 |
Why?
|
Colony-Forming Units Assay | 4 | 2013 | 354 | 0.390 |
Why?
|
Blood Platelets | 5 | 2018 | 2508 | 0.370 |
Why?
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2014 | 222 | 0.370 |
Why?
|
Granulocytes | 4 | 2017 | 547 | 0.350 |
Why?
|
Complement C3a | 2 | 2005 | 69 | 0.330 |
Why?
|
I Blood-Group System | 5 | 1995 | 8 | 0.330 |
Why?
|
Blood Group Antigens | 4 | 2015 | 180 | 0.300 |
Why?
|
Plasma Exchange | 6 | 1987 | 155 | 0.300 |
Why?
|
Immunoglobulin Idiotypes | 6 | 1995 | 201 | 0.300 |
Why?
|
Precursor Cells, B-Lymphoid | 1 | 2007 | 98 | 0.290 |
Why?
|
Antigens, Human Platelet | 2 | 2018 | 43 | 0.290 |
Why?
|
Myeloid Cells | 7 | 2017 | 809 | 0.290 |
Why?
|
Fusion Proteins, bcr-abl | 1 | 2009 | 434 | 0.290 |
Why?
|
Suppressor of Cytokine Signaling Proteins | 1 | 2007 | 176 | 0.290 |
Why?
|
Models, Animal | 1 | 2013 | 2171 | 0.290 |
Why?
|
PTEN Phosphohydrolase | 6 | 2015 | 1143 | 0.270 |
Why?
|
Receptors, Cytokine | 1 | 2006 | 261 | 0.260 |
Why?
|
Peritonitis | 3 | 2020 | 365 | 0.260 |
Why?
|
Animals | 58 | 2021 | 168788 | 0.260 |
Why?
|
Cell Cycle | 6 | 2013 | 2967 | 0.260 |
Why?
|
RGS Proteins | 1 | 2005 | 77 | 0.250 |
Why?
|
Cell Separation | 6 | 2017 | 1751 | 0.250 |
Why?
|
Receptors, Complement | 1 | 2005 | 264 | 0.250 |
Why?
|
Mice | 46 | 2021 | 81178 | 0.250 |
Why?
|
Blood Grouping and Crossmatching | 6 | 2018 | 106 | 0.250 |
Why?
|
Myeloma Proteins | 2 | 1995 | 71 | 0.240 |
Why?
|
Hematopoietic Stem Cell Transplantation | 7 | 2024 | 5442 | 0.240 |
Why?
|
Bone Marrow Transplantation | 8 | 2024 | 2763 | 0.240 |
Why?
|
Anemia, Sickle Cell | 2 | 2024 | 1018 | 0.240 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2016 | 4477 | 0.240 |
Why?
|
Cryoglobulins | 11 | 1995 | 59 | 0.240 |
Why?
|
Membrane Microdomains | 1 | 2005 | 203 | 0.240 |
Why?
|
Escherichia coli Infections | 2 | 2020 | 532 | 0.230 |
Why?
|
Cell Differentiation | 17 | 2020 | 11478 | 0.230 |
Why?
|
Plasmapheresis | 3 | 1991 | 212 | 0.230 |
Why?
|
Blood Banks | 3 | 1996 | 110 | 0.220 |
Why?
|
Gene Rearrangement, B-Lymphocyte | 4 | 1997 | 111 | 0.220 |
Why?
|
Transcription Factors | 7 | 2021 | 12207 | 0.220 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 3 | 1995 | 902 | 0.210 |
Why?
|
Base Sequence | 19 | 2005 | 12801 | 0.210 |
Why?
|
Phosphorylation | 8 | 2010 | 8437 | 0.210 |
Why?
|
Stromal Cells | 5 | 2012 | 1355 | 0.210 |
Why?
|
Flow Cytometry | 8 | 2017 | 5974 | 0.210 |
Why?
|
Leukemia | 2 | 2009 | 1508 | 0.210 |
Why?
|
Amino Acid Sequence | 19 | 2021 | 13817 | 0.200 |
Why?
|
Reactive Oxygen Species | 4 | 2017 | 2078 | 0.200 |
Why?
|
Mice, Knockout | 14 | 2015 | 14556 | 0.200 |
Why?
|
Cell Hypoxia | 2 | 2014 | 675 | 0.200 |
Why?
|
Splenomegaly | 2 | 2020 | 190 | 0.190 |
Why?
|
Receptors, CCR5 | 2 | 2002 | 497 | 0.190 |
Why?
|
Fetal Blood | 5 | 2013 | 1317 | 0.190 |
Why?
|
Molecular Sequence Data | 20 | 1999 | 18116 | 0.190 |
Why?
|
HIV Seropositivity | 2 | 1999 | 971 | 0.190 |
Why?
|
Multipotent Stem Cells | 2 | 2012 | 186 | 0.190 |
Why?
|
DNA, Complementary | 6 | 2014 | 2050 | 0.180 |
Why?
|
Bone Marrow Purging | 3 | 1996 | 109 | 0.180 |
Why?
|
Integrin alpha4beta1 | 3 | 2012 | 121 | 0.180 |
Why?
|
Blood Component Removal | 3 | 2000 | 125 | 0.180 |
Why?
|
Erythrocytes, Abnormal | 1 | 2020 | 125 | 0.180 |
Why?
|
Adult Stem Cells | 2 | 2013 | 216 | 0.180 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 4 | 2007 | 707 | 0.170 |
Why?
|
Herpesvirus 4, Human | 7 | 2000 | 1043 | 0.170 |
Why?
|
Embryonic Stem Cells | 2 | 2021 | 1294 | 0.170 |
Why?
|
Humans | 124 | 2024 | 744220 | 0.170 |
Why?
|
Apoptosis | 10 | 2021 | 9728 | 0.170 |
Why?
|
Cell Death | 4 | 2021 | 1708 | 0.170 |
Why?
|
Antibodies, Antiphospholipid | 1 | 1998 | 69 | 0.160 |
Why?
|
Lymphoma, B-Cell | 4 | 1995 | 931 | 0.160 |
Why?
|
Carbohydrates | 2 | 1993 | 393 | 0.160 |
Why?
|
Zinc Fingers | 1 | 2021 | 585 | 0.160 |
Why?
|
Mice, Inbred C57BL | 11 | 2017 | 21824 | 0.160 |
Why?
|
Cell Line, Transformed | 6 | 2009 | 898 | 0.160 |
Why?
|
Protein-Tyrosine Kinases | 2 | 2005 | 2455 | 0.160 |
Why?
|
HIV-2 | 1 | 1999 | 167 | 0.160 |
Why?
|
Hemagglutinins | 2 | 1995 | 117 | 0.160 |
Why?
|
Histone Demethylases | 1 | 2021 | 321 | 0.160 |
Why?
|
Cells, Cultured | 13 | 2020 | 19227 | 0.160 |
Why?
|
Antibodies, Monoclonal | 13 | 2001 | 9275 | 0.160 |
Why?
|
Immunoglobulin G | 5 | 2000 | 4559 | 0.150 |
Why?
|
Hematology | 1 | 2001 | 221 | 0.150 |
Why?
|
Neutropenia | 2 | 2021 | 895 | 0.150 |
Why?
|
MAP Kinase Signaling System | 1 | 2005 | 1525 | 0.150 |
Why?
|
Multigene Family | 3 | 1999 | 1102 | 0.150 |
Why?
|
Granulocyte Precursor Cells | 1 | 2017 | 43 | 0.150 |
Why?
|
Immunoglobulin kappa-Chains | 3 | 1992 | 173 | 0.150 |
Why?
|
Escherichia coli | 3 | 2020 | 4220 | 0.150 |
Why?
|
Virus Activation | 1 | 1999 | 319 | 0.140 |
Why?
|
Blood Component Transfusion | 2 | 2000 | 142 | 0.140 |
Why?
|
Hematopoietic Stem Cell Mobilization | 2 | 2012 | 227 | 0.140 |
Why?
|
ABO Blood-Group System | 3 | 2018 | 367 | 0.140 |
Why?
|
Receptors, Interleukin-8B | 1 | 2016 | 59 | 0.140 |
Why?
|
Myeloid Progenitor Cells | 2 | 2015 | 111 | 0.140 |
Why?
|
Homeostasis | 5 | 2020 | 3339 | 0.140 |
Why?
|
Stem Cell Factor | 2 | 2015 | 219 | 0.140 |
Why?
|
Antibodies, Anti-Idiotypic | 3 | 1995 | 349 | 0.140 |
Why?
|
Integrases | 2 | 2010 | 533 | 0.140 |
Why?
|
Cell Transformation, Viral | 4 | 1992 | 565 | 0.140 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2013 | 8950 | 0.140 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 2 | 2014 | 314 | 0.130 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 5 | 2009 | 1596 | 0.130 |
Why?
|
Lymphoproliferative Disorders | 3 | 2000 | 526 | 0.130 |
Why?
|
HIV-1 | 3 | 2000 | 6938 | 0.130 |
Why?
|
Cyclophosphamide | 5 | 1999 | 2236 | 0.130 |
Why?
|
Clone Cells | 7 | 1995 | 1692 | 0.130 |
Why?
|
Receptors, Antigen, B-Cell | 2 | 1996 | 548 | 0.130 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 1999 | 657 | 0.130 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2021 | 8426 | 0.130 |
Why?
|
Gammaretrovirus | 1 | 2014 | 54 | 0.130 |
Why?
|
Chemokines, CC | 2 | 2006 | 291 | 0.130 |
Why?
|
Radiation Chimera | 2 | 2011 | 223 | 0.130 |
Why?
|
X-Linked Combined Immunodeficiency Diseases | 1 | 2014 | 23 | 0.130 |
Why?
|
Signal Transduction | 11 | 2016 | 23404 | 0.130 |
Why?
|
Cloning, Molecular | 7 | 2000 | 4321 | 0.120 |
Why?
|
Ubiquitination | 2 | 2011 | 1011 | 0.120 |
Why?
|
Glutathione | 1 | 2017 | 588 | 0.120 |
Why?
|
rac GTP-Binding Proteins | 1 | 2015 | 164 | 0.120 |
Why?
|
Polymerase Chain Reaction | 9 | 2000 | 6172 | 0.120 |
Why?
|
DNA, Neoplasm | 3 | 2014 | 1758 | 0.120 |
Why?
|
Cold Temperature | 7 | 1993 | 774 | 0.120 |
Why?
|
Blotting, Southern | 5 | 1992 | 803 | 0.120 |
Why?
|
GTP-Binding Protein alpha Subunits, Gi-Go | 2 | 2005 | 89 | 0.120 |
Why?
|
16,16-Dimethylprostaglandin E2 | 1 | 2013 | 22 | 0.120 |
Why?
|
Phosphatidylinositol Phosphates | 3 | 2015 | 209 | 0.120 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 5 | 2021 | 11493 | 0.120 |
Why?
|
Cell Lineage | 4 | 2013 | 2504 | 0.120 |
Why?
|
Lymphocytes | 5 | 2012 | 2617 | 0.120 |
Why?
|
P Blood-Group System | 2 | 1994 | 3 | 0.110 |
Why?
|
Sequence Homology, Amino Acid | 6 | 2000 | 2839 | 0.110 |
Why?
|
Chemokines | 3 | 2005 | 969 | 0.110 |
Why?
|
Genes, Reporter | 3 | 2014 | 1547 | 0.110 |
Why?
|
HIV Core Protein p24 | 1 | 1993 | 256 | 0.110 |
Why?
|
Fibrin Tissue Adhesive | 1 | 1993 | 85 | 0.110 |
Why?
|
Spleen | 5 | 2013 | 2361 | 0.110 |
Why?
|
Blood Cells | 2 | 1994 | 309 | 0.110 |
Why?
|
Antibody Specificity | 6 | 1993 | 1095 | 0.110 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2018 | 1157 | 0.110 |
Why?
|
Phagocytosis | 2 | 2009 | 1538 | 0.110 |
Why?
|
Antigens, Differentiation | 2 | 2014 | 927 | 0.110 |
Why?
|
Nitroimidazoles | 1 | 2013 | 106 | 0.110 |
Why?
|
Animals, Congenic | 1 | 2011 | 27 | 0.110 |
Why?
|
Interleukin-7 | 1 | 2012 | 142 | 0.110 |
Why?
|
Research | 1 | 2001 | 1999 | 0.100 |
Why?
|
Membrane Proteins | 2 | 2007 | 7879 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-akt | 3 | 2011 | 2503 | 0.100 |
Why?
|
Antigens, Neoplasm | 1 | 2000 | 1987 | 0.100 |
Why?
|
Cell Proliferation | 7 | 2021 | 10480 | 0.100 |
Why?
|
Immunoblotting | 3 | 2007 | 1682 | 0.100 |
Why?
|
Interleukin-1beta | 1 | 2017 | 972 | 0.100 |
Why?
|
Immunoprecipitation | 3 | 2009 | 905 | 0.100 |
Why?
|
Homeodomain Proteins | 2 | 2012 | 2422 | 0.100 |
Why?
|
Cyclohexanones | 1 | 2011 | 30 | 0.100 |
Why?
|
Erythrocyte Membrane | 1 | 1993 | 442 | 0.100 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2013 | 431 | 0.100 |
Why?
|
Lymphocyte Activation | 5 | 1996 | 5523 | 0.100 |
Why?
|
Bacteriophages | 1 | 1994 | 358 | 0.100 |
Why?
|
Transfection | 5 | 2009 | 5892 | 0.100 |
Why?
|
Ki-67 Antigen | 1 | 2013 | 644 | 0.100 |
Why?
|
Mice, SCID | 5 | 2021 | 2716 | 0.090 |
Why?
|
Cord Blood Stem Cell Transplantation | 1 | 2013 | 314 | 0.090 |
Why?
|
Immunoglobulins | 2 | 1993 | 881 | 0.090 |
Why?
|
Rheumatoid Factor | 1 | 1991 | 188 | 0.090 |
Why?
|
Lymphopenia | 1 | 2012 | 285 | 0.090 |
Why?
|
Mice, Inbred NOD | 4 | 2021 | 1877 | 0.090 |
Why?
|
Muscles | 5 | 2002 | 1622 | 0.090 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2014 | 581 | 0.090 |
Why?
|
Leukemia, Monocytic, Acute | 1 | 2010 | 58 | 0.090 |
Why?
|
Anti-Inflammatory Agents | 2 | 2018 | 1789 | 0.090 |
Why?
|
Mitogen-Activated Protein Kinases | 3 | 2005 | 1284 | 0.090 |
Why?
|
Cytomegalovirus Infections | 2 | 1999 | 821 | 0.090 |
Why?
|
Lymphoma, Non-Hodgkin | 2 | 1996 | 1380 | 0.090 |
Why?
|
Receptors, CCR7 | 2 | 2008 | 108 | 0.090 |
Why?
|
Neoplasm Proteins | 2 | 2014 | 3703 | 0.090 |
Why?
|
Femur | 2 | 2013 | 1297 | 0.090 |
Why?
|
Teratoma | 1 | 2012 | 387 | 0.090 |
Why?
|
Single-Cell Analysis | 1 | 2020 | 2183 | 0.090 |
Why?
|
Triterpenes | 1 | 2010 | 80 | 0.090 |
Why?
|
Chemotaxis, Leukocyte | 1 | 2012 | 675 | 0.090 |
Why?
|
Neovascularization, Pathologic | 1 | 2020 | 2636 | 0.090 |
Why?
|
Antibodies, Anticardiolipin | 2 | 2000 | 62 | 0.090 |
Why?
|
Proto-Oncogene Proteins | 3 | 2013 | 4553 | 0.090 |
Why?
|
Research Support as Topic | 1 | 2014 | 704 | 0.090 |
Why?
|
Multiple Myeloma | 3 | 1995 | 5180 | 0.090 |
Why?
|
DNA Methylation | 2 | 2021 | 4289 | 0.090 |
Why?
|
Fluorescent Antibody Technique | 3 | 2009 | 2505 | 0.090 |
Why?
|
Receptors, Interleukin-21 | 1 | 2008 | 33 | 0.090 |
Why?
|
RNA Interference | 2 | 2009 | 2890 | 0.090 |
Why?
|
Purpura, Thrombotic Thrombocytopenic | 2 | 1987 | 131 | 0.090 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2013 | 627 | 0.080 |
Why?
|
Fibrinogen | 2 | 1993 | 894 | 0.080 |
Why?
|
Protein Processing, Post-Translational | 1 | 2017 | 1990 | 0.080 |
Why?
|
Leukocytes | 2 | 2000 | 2040 | 0.080 |
Why?
|
Erythropoietin | 1 | 1993 | 724 | 0.080 |
Why?
|
Cryopreservation | 4 | 2017 | 670 | 0.080 |
Why?
|
Immunoglobulin A | 1 | 1992 | 992 | 0.080 |
Why?
|
Recombinant Proteins | 2 | 2000 | 6612 | 0.080 |
Why?
|
Tumor Cells, Cultured | 4 | 2021 | 6313 | 0.080 |
Why?
|
Cysteine | 3 | 2017 | 874 | 0.080 |
Why?
|
STAT5 Transcription Factor | 1 | 2009 | 259 | 0.080 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2021 | 2214 | 0.080 |
Why?
|
Gene Expression Profiling | 4 | 2020 | 9438 | 0.080 |
Why?
|
Inflammation | 3 | 2017 | 10634 | 0.080 |
Why?
|
DNA-Binding Proteins | 2 | 2021 | 9647 | 0.080 |
Why?
|
Pneumonia, Bacterial | 1 | 2011 | 316 | 0.080 |
Why?
|
Gene Expression | 6 | 2014 | 7799 | 0.080 |
Why?
|
Utilization Review | 1 | 1989 | 392 | 0.080 |
Why?
|
Cell Line | 10 | 2009 | 15999 | 0.080 |
Why?
|
Leukocyte Transfusion | 2 | 2021 | 60 | 0.080 |
Why?
|
Program Development | 1 | 2014 | 1315 | 0.080 |
Why?
|
Refrigeration | 1 | 2007 | 29 | 0.080 |
Why?
|
rap1 GTP-Binding Proteins | 1 | 2007 | 60 | 0.070 |
Why?
|
Peer Review | 1 | 1989 | 209 | 0.070 |
Why?
|
Antigens, CD34 | 3 | 2014 | 657 | 0.070 |
Why?
|
Myelopoiesis | 1 | 2008 | 133 | 0.070 |
Why?
|
Hematopoietic System | 1 | 2007 | 109 | 0.070 |
Why?
|
Nucleic Acid Heteroduplexes | 2 | 1997 | 47 | 0.070 |
Why?
|
Chemokine CCL19 | 1 | 2006 | 35 | 0.070 |
Why?
|
Splenectomy | 2 | 1987 | 395 | 0.070 |
Why?
|
Gene Knockdown Techniques | 3 | 2021 | 1655 | 0.070 |
Why?
|
Tissue Adhesives | 1 | 1988 | 179 | 0.070 |
Why?
|
Chemokine CCL21 | 1 | 2006 | 51 | 0.070 |
Why?
|
Neutrophil Infiltration | 1 | 2009 | 390 | 0.070 |
Why?
|
Amino Acid Motifs | 2 | 2021 | 936 | 0.070 |
Why?
|
T-Lymphocytes | 4 | 2014 | 10182 | 0.070 |
Why?
|
Tubulin | 1 | 2010 | 695 | 0.070 |
Why?
|
Receptors, CXCR5 | 1 | 2006 | 92 | 0.070 |
Why?
|
Endothelium, Vascular | 1 | 1998 | 4455 | 0.070 |
Why?
|
Receptors, CCR6 | 1 | 2006 | 81 | 0.070 |
Why?
|
Blood Preservation | 1 | 2007 | 177 | 0.070 |
Why?
|
Antigens, Ly | 1 | 2007 | 291 | 0.070 |
Why?
|
Cell Transplantation | 1 | 2008 | 477 | 0.070 |
Why?
|
Amniotic Fluid | 1 | 2008 | 370 | 0.070 |
Why?
|
Anaphylatoxins | 1 | 2005 | 21 | 0.070 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2011 | 689 | 0.070 |
Why?
|
Ear, Middle | 1 | 1988 | 334 | 0.070 |
Why?
|
Myosins | 2 | 1988 | 409 | 0.070 |
Why?
|
Galactose | 1 | 2007 | 306 | 0.070 |
Why?
|
Microscopy, Fluorescence | 1 | 2013 | 2700 | 0.070 |
Why?
|
von Willebrand Diseases | 1 | 1987 | 127 | 0.070 |
Why?
|
Cell Division | 5 | 2011 | 4567 | 0.070 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 1 | 2008 | 437 | 0.070 |
Why?
|
Isoelectric Focusing | 3 | 1991 | 181 | 0.070 |
Why?
|
Enzyme Activation | 3 | 2008 | 3701 | 0.070 |
Why?
|
Immunoglobulin Light Chains | 2 | 2000 | 277 | 0.070 |
Why?
|
Cell Movement | 6 | 2013 | 5216 | 0.070 |
Why?
|
Receptor, Anaphylatoxin C5a | 1 | 2005 | 90 | 0.060 |
Why?
|
Cell Migration Inhibition | 1 | 2005 | 96 | 0.060 |
Why?
|
Retinoblastoma-Like Protein p130 | 1 | 2005 | 76 | 0.060 |
Why?
|
Phenytoin | 1 | 1986 | 197 | 0.060 |
Why?
|
Mutagenesis, Site-Directed | 2 | 2007 | 1724 | 0.060 |
Why?
|
Pyridines | 2 | 2021 | 2822 | 0.060 |
Why?
|
Genes, Tumor Suppressor | 1 | 2009 | 1097 | 0.060 |
Why?
|
Male | 25 | 2020 | 350027 | 0.060 |
Why?
|
Isoantigens | 2 | 2001 | 567 | 0.060 |
Why?
|
Genetic Vectors | 1 | 2014 | 3420 | 0.060 |
Why?
|
Mitosis | 1 | 2010 | 1208 | 0.060 |
Why?
|
Pneumonia | 1 | 2016 | 2134 | 0.060 |
Why?
|
Sequence Alignment | 3 | 1995 | 2256 | 0.060 |
Why?
|
Lentivirus | 1 | 2007 | 501 | 0.060 |
Why?
|
Cell Communication | 1 | 2011 | 1621 | 0.060 |
Why?
|
Histone Deacetylases | 1 | 2009 | 729 | 0.060 |
Why?
|
HeLa Cells | 3 | 2021 | 3129 | 0.060 |
Why?
|
Lymphoma | 2 | 1993 | 1873 | 0.060 |
Why?
|
Immunization | 1 | 2008 | 1256 | 0.060 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2005 | 2938 | 0.060 |
Why?
|
Microtubules | 1 | 2010 | 1091 | 0.060 |
Why?
|
Myocytes, Cardiac | 1 | 2013 | 1637 | 0.060 |
Why?
|
Adult | 24 | 2018 | 214035 | 0.060 |
Why?
|
Disease Models, Animal | 5 | 2020 | 18027 | 0.060 |
Why?
|
Gene Expression Regulation | 3 | 2014 | 12075 | 0.060 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2006 | 625 | 0.060 |
Why?
|
Female | 27 | 2020 | 380197 | 0.060 |
Why?
|
Glycoproteins | 3 | 2001 | 2263 | 0.060 |
Why?
|
Chemokine CXCL2 | 2 | 2016 | 111 | 0.060 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 1998 | 3871 | 0.060 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2009 | 4752 | 0.060 |
Why?
|
Sequence Homology, Nucleic Acid | 3 | 1995 | 1086 | 0.060 |
Why?
|
Antibodies, Neoplasm | 2 | 1995 | 286 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2007 | 774 | 0.060 |
Why?
|
Carbohydrate Sequence | 2 | 1994 | 414 | 0.060 |
Why?
|
Graft Survival | 1 | 2013 | 3740 | 0.050 |
Why?
|
Oxygen | 1 | 2014 | 4187 | 0.050 |
Why?
|
Trans-Activators | 1 | 2013 | 2924 | 0.050 |
Why?
|
Gene Library | 2 | 1995 | 1076 | 0.050 |
Why?
|
Sequence Analysis, RNA | 2 | 2021 | 2013 | 0.050 |
Why?
|
Recombinant Fusion Proteins | 4 | 2011 | 3772 | 0.050 |
Why?
|
HIV | 2 | 2000 | 1604 | 0.050 |
Why?
|
src-Family Kinases | 1 | 2005 | 551 | 0.050 |
Why?
|
Transplantation, Autologous | 4 | 1996 | 2124 | 0.050 |
Why?
|
Dermatitis, Atopic | 1 | 2008 | 654 | 0.050 |
Why?
|
DNA Primers | 3 | 1995 | 2892 | 0.050 |
Why?
|
Hematologic Neoplasms | 1 | 2013 | 1831 | 0.050 |
Why?
|
Breast Neoplasms | 3 | 1999 | 20817 | 0.050 |
Why?
|
Circadian Rhythm | 1 | 2013 | 2624 | 0.050 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 1983 | 365 | 0.050 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2012 | 1736 | 0.050 |
Why?
|
Carcinoma, Small Cell | 1 | 2003 | 420 | 0.050 |
Why?
|
Blood Cell Count | 2 | 2008 | 402 | 0.050 |
Why?
|
Down-Regulation | 2 | 2006 | 3001 | 0.050 |
Why?
|
Blood Substitutes | 1 | 2001 | 58 | 0.050 |
Why?
|
Coronary Artery Bypass | 1 | 1990 | 2289 | 0.050 |
Why?
|
Fetus | 2 | 1999 | 1880 | 0.050 |
Why?
|
Actins | 2 | 2005 | 2121 | 0.050 |
Why?
|
Protein Binding | 4 | 2021 | 9392 | 0.050 |
Why?
|
Glycolipids | 2 | 1994 | 205 | 0.050 |
Why?
|
Stem Cells | 2 | 2007 | 3567 | 0.050 |
Why?
|
Tyrosine | 1 | 2005 | 1461 | 0.050 |
Why?
|
Mesenchymal Stem Cell Transplantation | 1 | 2005 | 495 | 0.050 |
Why?
|
Blast Crisis | 2 | 2011 | 103 | 0.050 |
Why?
|
Enzyme Inhibitors | 1 | 2011 | 3800 | 0.050 |
Why?
|
Reading Frames | 1 | 1999 | 19 | 0.040 |
Why?
|
Repressor Proteins | 2 | 2011 | 3023 | 0.040 |
Why?
|
Mice, Transgenic | 4 | 2015 | 9735 | 0.040 |
Why?
|
Genomics | 1 | 2015 | 5722 | 0.040 |
Why?
|
Heart | 1 | 2013 | 4465 | 0.040 |
Why?
|
Herpesvirus 7, Human | 1 | 1999 | 12 | 0.040 |
Why?
|
beta 2-Glycoprotein I | 1 | 1998 | 28 | 0.040 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2021 | 3557 | 0.040 |
Why?
|
Forecasting | 2 | 2001 | 2949 | 0.040 |
Why?
|
Protein Transport | 1 | 2005 | 1989 | 0.040 |
Why?
|
HIV Antigens | 1 | 2000 | 347 | 0.040 |
Why?
|
Bone Marrow Neoplasms | 1 | 1999 | 104 | 0.040 |
Why?
|
Protein Array Analysis | 1 | 2021 | 411 | 0.040 |
Why?
|
Thiotepa | 2 | 1999 | 66 | 0.040 |
Why?
|
Gene Expression Regulation, Leukemic | 2 | 2014 | 651 | 0.040 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2009 | 4419 | 0.040 |
Why?
|
Antibodies, Antinuclear | 1 | 2000 | 326 | 0.040 |
Why?
|
Graft vs Host Disease | 1 | 1991 | 2957 | 0.040 |
Why?
|
Oligonucleotides | 2 | 1991 | 572 | 0.040 |
Why?
|
Transplantation | 1 | 2000 | 217 | 0.040 |
Why?
|
Immunohistochemistry | 3 | 2009 | 11368 | 0.040 |
Why?
|
Herpesvirus 6, Human | 1 | 1999 | 95 | 0.040 |
Why?
|
Autoantigens | 2 | 1994 | 892 | 0.040 |
Why?
|
Proline | 1 | 2000 | 458 | 0.040 |
Why?
|
Models, Biological | 1 | 2014 | 9582 | 0.040 |
Why?
|
Protein Kinase C | 1 | 2003 | 1227 | 0.040 |
Why?
|
Immunologic Memory | 1 | 2005 | 1348 | 0.040 |
Why?
|
Tissue Engineering | 1 | 2008 | 1880 | 0.040 |
Why?
|
Glutaredoxins | 1 | 2017 | 32 | 0.040 |
Why?
|
Phosphate-Binding Proteins | 1 | 2018 | 70 | 0.040 |
Why?
|
Waldenstrom Macroglobulinemia | 1 | 1987 | 1052 | 0.040 |
Why?
|
Blood Transfusion, Autologous | 2 | 1988 | 134 | 0.040 |
Why?
|
Autoimmunity | 2 | 1995 | 1349 | 0.040 |
Why?
|
HEK293 Cells | 2 | 2021 | 4201 | 0.040 |
Why?
|
Blotting, Western | 2 | 2017 | 5180 | 0.040 |
Why?
|
Hybridomas | 2 | 1992 | 452 | 0.040 |
Why?
|
Antineoplastic Agents | 4 | 2011 | 13668 | 0.040 |
Why?
|
Herpesviridae Infections | 1 | 1999 | 277 | 0.040 |
Why?
|
Antiphospholipid Syndrome | 1 | 1998 | 173 | 0.040 |
Why?
|
Herpesvirus 8, Human | 1 | 1999 | 258 | 0.040 |
Why?
|
Pregnancy | 6 | 2013 | 29142 | 0.040 |
Why?
|
Nuclear Proteins | 2 | 2011 | 5853 | 0.030 |
Why?
|
Parental Consent | 1 | 1996 | 62 | 0.030 |
Why?
|
Immunoglobulin gamma-Chains | 1 | 1995 | 33 | 0.030 |
Why?
|
Hemagglutination Inhibition Tests | 1 | 1995 | 77 | 0.030 |
Why?
|
Hemorrhage | 1 | 1988 | 3461 | 0.030 |
Why?
|
Immunoglobulin Constant Regions | 1 | 1995 | 59 | 0.030 |
Why?
|
Immunoglobulin mu-Chains | 1 | 1995 | 63 | 0.030 |
Why?
|
Benzamides | 1 | 2021 | 1378 | 0.030 |
Why?
|
Erythropoiesis | 1 | 2000 | 705 | 0.030 |
Why?
|
Megakaryocytes | 1 | 1999 | 545 | 0.030 |
Why?
|
Phenotype | 4 | 2005 | 16365 | 0.030 |
Why?
|
Plasma | 2 | 1989 | 575 | 0.030 |
Why?
|
Chromatin Immunoprecipitation | 2 | 2009 | 893 | 0.030 |
Why?
|
Arthritis, Rheumatoid | 1 | 1991 | 3712 | 0.030 |
Why?
|
Karyotyping | 2 | 1988 | 1243 | 0.030 |
Why?
|
Reference Values | 1 | 2002 | 4982 | 0.030 |
Why?
|
Skin | 1 | 2008 | 4363 | 0.030 |
Why?
|
Antibody Formation | 1 | 2000 | 1402 | 0.030 |
Why?
|
Blood Group Incompatibility | 1 | 1996 | 145 | 0.030 |
Why?
|
Phospholipids | 1 | 1998 | 781 | 0.030 |
Why?
|
Acute Disease | 2 | 2016 | 7148 | 0.030 |
Why?
|
DNA | 4 | 1998 | 7303 | 0.030 |
Why?
|
Calcium | 2 | 2000 | 5757 | 0.030 |
Why?
|
Interleukin Receptor Common gamma Subunit | 1 | 2014 | 88 | 0.030 |
Why?
|
Risk Assessment | 1 | 1996 | 23337 | 0.030 |
Why?
|
Middle Aged | 15 | 2018 | 213367 | 0.030 |
Why?
|
Infant, Newborn | 6 | 2013 | 25618 | 0.030 |
Why?
|
Sequence Homology | 1 | 1995 | 203 | 0.030 |
Why?
|
Protein Kinase Inhibitors | 1 | 2011 | 5529 | 0.030 |
Why?
|
Lymphocyte Subsets | 1 | 1996 | 315 | 0.030 |
Why?
|
Cell Survival | 3 | 2014 | 5881 | 0.030 |
Why?
|
Oligodeoxyribonucleotides | 2 | 1993 | 708 | 0.030 |
Why?
|
Histocompatibility Testing | 1 | 1996 | 742 | 0.030 |
Why?
|
Neoplasms | 2 | 2021 | 21672 | 0.030 |
Why?
|
Adoptive Transfer | 2 | 2008 | 844 | 0.030 |
Why?
|
Transplantation, Heterologous | 2 | 2012 | 2382 | 0.030 |
Why?
|
Hematopoietic Cell Growth Factors | 1 | 1994 | 102 | 0.030 |
Why?
|
Forms and Records Control | 1 | 2014 | 160 | 0.030 |
Why?
|
Erythrocyte Transfusion | 2 | 1989 | 565 | 0.030 |
Why?
|
Laser Scanning Cytometry | 1 | 2013 | 5 | 0.030 |
Why?
|
Neoplasm Transplantation | 2 | 2012 | 2085 | 0.030 |
Why?
|
Factor XIII | 1 | 1993 | 59 | 0.030 |
Why?
|
Cell Membrane | 2 | 2002 | 3748 | 0.030 |
Why?
|
Mice, Mutant Strains | 1 | 2017 | 1866 | 0.030 |
Why?
|
Hemagglutination | 2 | 1992 | 34 | 0.030 |
Why?
|
Paracrine Communication | 1 | 2015 | 276 | 0.030 |
Why?
|
Hemagglutination Tests | 1 | 1992 | 75 | 0.030 |
Why?
|
Orphan Nuclear Receptors | 1 | 2013 | 60 | 0.030 |
Why?
|
Immunoelectrophoresis | 1 | 1992 | 110 | 0.030 |
Why?
|
Cattle | 1 | 1999 | 3922 | 0.030 |
Why?
|
Ligands | 2 | 2016 | 3294 | 0.030 |
Why?
|
Immunophenotyping | 2 | 2015 | 1880 | 0.030 |
Why?
|
Protein Sorting Signals | 1 | 1993 | 281 | 0.030 |
Why?
|
Cell Enlargement | 1 | 2013 | 61 | 0.030 |
Why?
|
Acetylcholinesterase | 2 | 1983 | 153 | 0.030 |
Why?
|
Cardiolipins | 1 | 1992 | 88 | 0.030 |
Why?
|
Neoplastic Cells, Circulating | 1 | 1999 | 933 | 0.030 |
Why?
|
Sirolimus | 1 | 2000 | 1563 | 0.030 |
Why?
|
Ploidies | 1 | 2013 | 281 | 0.030 |
Why?
|
Gene Frequency | 1 | 1999 | 3588 | 0.030 |
Why?
|
STAT3 Transcription Factor | 1 | 2016 | 874 | 0.030 |
Why?
|
Immunoglobulin Fab Fragments | 1 | 1994 | 482 | 0.030 |
Why?
|
Hemoglobinuria, Paroxysmal | 1 | 1993 | 102 | 0.030 |
Why?
|
Epitopes | 1 | 1998 | 2571 | 0.030 |
Why?
|
Wiskott-Aldrich Syndrome | 1 | 1992 | 131 | 0.030 |
Why?
|
RNA, Neoplasm | 1 | 1995 | 769 | 0.030 |
Why?
|
HIV Infections | 2 | 1995 | 16718 | 0.020 |
Why?
|
Transduction, Genetic | 1 | 2014 | 913 | 0.020 |
Why?
|
Lung Injury | 1 | 2016 | 436 | 0.020 |
Why?
|
Centrifugation, Density Gradient | 2 | 1989 | 313 | 0.020 |
Why?
|
Leukemia, Myeloid, Chronic-Phase | 1 | 2011 | 38 | 0.020 |
Why?
|
Cell Line, Tumor | 2 | 2021 | 16687 | 0.020 |
Why?
|
Restriction Mapping | 1 | 1991 | 878 | 0.020 |
Why?
|
Platelet Count | 1 | 1994 | 781 | 0.020 |
Why?
|
Transgenes | 1 | 2014 | 1009 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2018 | 1782 | 0.020 |
Why?
|
Introns | 1 | 1993 | 991 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2017 | 1971 | 0.020 |
Why?
|
Transplantation Chimera | 1 | 2013 | 612 | 0.020 |
Why?
|
Carboplatin | 1 | 1994 | 800 | 0.020 |
Why?
|
Pentacyclic Triterpenes | 1 | 2010 | 37 | 0.020 |
Why?
|
Caspases | 1 | 2014 | 928 | 0.020 |
Why?
|
Adipogenesis | 1 | 2013 | 359 | 0.020 |
Why?
|
Polymorphism, Genetic | 1 | 2001 | 4328 | 0.020 |
Why?
|
Product Surveillance, Postmarketing | 1 | 2014 | 430 | 0.020 |
Why?
|
Mice, Inbred Strains | 1 | 2013 | 1827 | 0.020 |
Why?
|
Education | 1 | 2013 | 543 | 0.020 |
Why?
|
Phosphatidylinositols | 1 | 2011 | 291 | 0.020 |
Why?
|
Osteogenesis | 1 | 2017 | 1299 | 0.020 |
Why?
|
Perinatology | 1 | 1990 | 57 | 0.020 |
Why?
|
Leukocyte Count | 1 | 1994 | 1584 | 0.020 |
Why?
|
Proteins | 1 | 2005 | 6101 | 0.020 |
Why?
|
Allosteric Regulation | 1 | 2011 | 408 | 0.020 |
Why?
|
Alleles | 3 | 2014 | 6938 | 0.020 |
Why?
|
Joint Commission on Accreditation of Healthcare Organizations | 1 | 1989 | 93 | 0.020 |
Why?
|
United States | 6 | 2014 | 69867 | 0.020 |
Why?
|
Leukocyte Rolling | 1 | 2009 | 72 | 0.020 |
Why?
|
Osteoblasts | 1 | 2015 | 1165 | 0.020 |
Why?
|
Blood Vessels | 1 | 2015 | 1126 | 0.020 |
Why?
|
Microscopy, Video | 1 | 2009 | 245 | 0.020 |
Why?
|
Binding, Competitive | 1 | 1990 | 1159 | 0.020 |
Why?
|
Lipopolysaccharides | 1 | 2016 | 2216 | 0.020 |
Why?
|
Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2009 | 113 | 0.020 |
Why?
|
Keratinocytes | 1 | 2012 | 798 | 0.020 |
Why?
|
Protein Stability | 1 | 2010 | 557 | 0.020 |
Why?
|
Amniocentesis | 1 | 2008 | 116 | 0.020 |
Why?
|
Diffusion of Innovation | 1 | 2013 | 725 | 0.020 |
Why?
|
Wnt Proteins | 1 | 2012 | 721 | 0.020 |
Why?
|
Inositol 1,4,5-Trisphosphate | 1 | 2008 | 114 | 0.020 |
Why?
|
Tympanoplasty | 1 | 1988 | 71 | 0.020 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 1999 | 3617 | 0.020 |
Why?
|
Kinetics | 3 | 1986 | 6474 | 0.020 |
Why?
|
Aged | 8 | 2021 | 163253 | 0.020 |
Why?
|
Gene Silencing | 1 | 2014 | 1538 | 0.020 |
Why?
|
Adrenal Cortex Hormones | 2 | 1987 | 1854 | 0.020 |
Why?
|
Cell Transformation, Neoplastic | 1 | 1998 | 2942 | 0.020 |
Why?
|
Bleeding Time | 1 | 1987 | 89 | 0.020 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2018 | 2916 | 0.020 |
Why?
|
Factor VIII | 1 | 1989 | 348 | 0.020 |
Why?
|
Dithiothreitol | 1 | 1987 | 101 | 0.020 |
Why?
|
Bone Neoplasms | 1 | 1999 | 2525 | 0.020 |
Why?
|
Interdisciplinary Communication | 1 | 2013 | 950 | 0.020 |
Why?
|
Adiposity | 1 | 2017 | 1807 | 0.020 |
Why?
|
Needs Assessment | 1 | 2013 | 1147 | 0.020 |
Why?
|
Placenta | 1 | 1996 | 1697 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2000 | 4151 | 0.020 |
Why?
|
Ovalbumin | 1 | 2008 | 719 | 0.020 |
Why?
|
Immunosorbent Techniques | 1 | 1986 | 184 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2010 | 1799 | 0.020 |
Why?
|
Nucleic Acid Hybridization | 1 | 1988 | 1375 | 0.020 |
Why?
|
HL-60 Cells | 1 | 2007 | 365 | 0.020 |
Why?
|
Promoter Regions, Genetic | 2 | 2009 | 5867 | 0.020 |
Why?
|
Iodine Radioisotopes | 1 | 1990 | 1032 | 0.020 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2008 | 472 | 0.020 |
Why?
|
Blood Volume | 1 | 1988 | 565 | 0.020 |
Why?
|
Endothelium | 1 | 2009 | 778 | 0.020 |
Why?
|
Serum Albumin | 1 | 1989 | 676 | 0.020 |
Why?
|
Blood Loss, Surgical | 1 | 1990 | 661 | 0.020 |
Why?
|
Lung | 2 | 2016 | 9852 | 0.020 |
Why?
|
Amino Acid Substitution | 1 | 2011 | 1792 | 0.020 |
Why?
|
Cooperative Behavior | 1 | 2013 | 1504 | 0.020 |
Why?
|
Citrates | 1 | 1986 | 131 | 0.020 |
Why?
|
Fibrosis | 1 | 2013 | 2029 | 0.020 |
Why?
|
Drug Synergism | 1 | 2010 | 1791 | 0.020 |
Why?
|
Immunotherapy, Adoptive | 1 | 2014 | 1269 | 0.020 |
Why?
|
Cell Shape | 1 | 2007 | 375 | 0.020 |
Why?
|
Leukemia, Promyelocytic, Acute | 1 | 2007 | 236 | 0.020 |
Why?
|
Body Temperature | 1 | 1989 | 777 | 0.020 |
Why?
|
Shock | 1 | 1988 | 318 | 0.020 |
Why?
|
Muscular Dystrophies | 1 | 1988 | 393 | 0.020 |
Why?
|
Immunoglobulin Allotypes | 1 | 1985 | 56 | 0.020 |
Why?
|
Evaluation Studies as Topic | 1 | 1987 | 1676 | 0.020 |
Why?
|
Luciferases | 1 | 2007 | 733 | 0.020 |
Why?
|
Data Collection | 1 | 2014 | 3340 | 0.020 |
Why?
|
Hepatomegaly | 1 | 1985 | 85 | 0.020 |
Why?
|
Hypergammaglobulinemia | 1 | 1985 | 74 | 0.020 |
Why?
|
Osteosclerosis | 1 | 1985 | 39 | 0.020 |
Why?
|
Liver Neoplasms | 1 | 2021 | 4252 | 0.020 |
Why?
|
Protein Multimerization | 1 | 2010 | 971 | 0.020 |
Why?
|
Integrin alpha4 | 1 | 2005 | 92 | 0.020 |
Why?
|
Transplantation, Homologous | 1 | 2013 | 4776 | 0.020 |
Why?
|
Selectins | 1 | 2005 | 102 | 0.020 |
Why?
|
Genome, Human | 1 | 2018 | 4420 | 0.020 |
Why?
|
Immunoglobulin lambda-Chains | 1 | 1985 | 87 | 0.020 |
Why?
|
Heterotrimeric GTP-Binding Proteins | 1 | 2005 | 93 | 0.020 |
Why?
|
Fever | 1 | 1992 | 1614 | 0.020 |
Why?
|
Calcium Signaling | 1 | 2009 | 721 | 0.020 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 1993 | 2234 | 0.020 |
Why?
|
Cytarabine | 1 | 1986 | 692 | 0.020 |
Why?
|
Retroviridae | 1 | 2007 | 914 | 0.020 |
Why?
|
Clinical Protocols | 1 | 1990 | 1462 | 0.020 |
Why?
|
Mathematics | 1 | 1986 | 728 | 0.020 |
Why?
|
Algorithms | 2 | 2018 | 13885 | 0.020 |
Why?
|
Combined Modality Therapy | 2 | 2011 | 8628 | 0.010 |
Why?
|
Bone and Bones | 1 | 2015 | 2575 | 0.010 |
Why?
|
Rubella | 1 | 1984 | 48 | 0.010 |
Why?
|
Interleukins | 1 | 2008 | 791 | 0.010 |
Why?
|
Treatment Outcome | 4 | 2014 | 63119 | 0.010 |
Why?
|
Anemia | 1 | 1993 | 1504 | 0.010 |
Why?
|
Blood Coagulation Disorders | 1 | 1987 | 337 | 0.010 |
Why?
|
Quality Control | 1 | 1986 | 843 | 0.010 |
Why?
|
Regeneration | 1 | 2013 | 1485 | 0.010 |
Why?
|
Fluid Therapy | 1 | 1988 | 593 | 0.010 |
Why?
|
RNA, Messenger | 2 | 1999 | 13036 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2011 | 3846 | 0.010 |
Why?
|
Glycosylation | 1 | 2007 | 1126 | 0.010 |
Why?
|
Liver | 1 | 1999 | 7472 | 0.010 |
Why?
|
Myelodysplastic Syndromes | 1 | 1993 | 1352 | 0.010 |
Why?
|
Myasthenia Gravis | 1 | 1986 | 201 | 0.010 |
Why?
|
Immunity, Innate | 1 | 1995 | 2958 | 0.010 |
Why?
|
Collagen Diseases | 1 | 1983 | 34 | 0.010 |
Why?
|
Chromium Radioisotopes | 1 | 1983 | 36 | 0.010 |
Why?
|
Specimen Handling | 1 | 2008 | 694 | 0.010 |
Why?
|
Resuscitation | 1 | 1988 | 657 | 0.010 |
Why?
|
Chromosome Disorders | 1 | 1986 | 515 | 0.010 |
Why?
|
Mutation | 3 | 2014 | 29784 | 0.010 |
Why?
|
Gestational Age | 2 | 2008 | 3493 | 0.010 |
Why?
|
Monocytes | 1 | 1992 | 2594 | 0.010 |
Why?
|
Cell Adhesion Molecules | 1 | 2009 | 1602 | 0.010 |
Why?
|
Up-Regulation | 1 | 2012 | 4217 | 0.010 |
Why?
|
Adrenal Insufficiency | 1 | 1985 | 184 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2011 | 4929 | 0.010 |
Why?
|
Neoplastic Stem Cells | 1 | 2011 | 1376 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 1991 | 4188 | 0.010 |
Why?
|
Membrane Glycoproteins | 1 | 1994 | 3769 | 0.010 |
Why?
|
Microsurgery | 1 | 1988 | 796 | 0.010 |
Why?
|
Receptors, Cholinergic | 1 | 1983 | 238 | 0.010 |
Why?
|
DEAE-Cellulose | 1 | 1982 | 1 | 0.010 |
Why?
|
Muscle Contraction | 2 | 1988 | 1241 | 0.010 |
Why?
|
DEAE-Dextran | 1 | 1982 | 10 | 0.010 |
Why?
|
Prenatal Care | 1 | 1990 | 1092 | 0.010 |
Why?
|
Interleukin-1 | 1 | 1986 | 1263 | 0.010 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 1985 | 1801 | 0.010 |
Why?
|
Complement C4 | 1 | 1983 | 257 | 0.010 |
Why?
|
Internet | 1 | 2014 | 3063 | 0.010 |
Why?
|
Endothelial Cells | 1 | 2015 | 3478 | 0.010 |
Why?
|
Adolescent | 4 | 2018 | 85759 | 0.010 |
Why?
|
Cyclic AMP | 1 | 1986 | 1471 | 0.010 |
Why?
|
Recurrence | 1 | 1994 | 8343 | 0.010 |
Why?
|
Mass Spectrometry | 1 | 2009 | 2204 | 0.010 |
Why?
|
Infant | 2 | 2014 | 35129 | 0.010 |
Why?
|
Antigens, Surface | 1 | 1986 | 1663 | 0.010 |
Why?
|
Isoenzymes | 1 | 1986 | 1726 | 0.010 |
Why?
|
Cellulose | 1 | 1982 | 123 | 0.010 |
Why?
|
Mutation, Missense | 1 | 2011 | 2563 | 0.010 |
Why?
|
Guidelines as Topic | 1 | 2008 | 1404 | 0.010 |
Why?
|
Emergencies | 1 | 1988 | 1170 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2018 | 9960 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 1999 | 9230 | 0.010 |
Why?
|
Biological Products | 1 | 2010 | 860 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2009 | 3921 | 0.010 |
Why?
|
Kidney Failure, Chronic | 1 | 1993 | 2538 | 0.010 |
Why?
|
Complement C3 | 1 | 1983 | 461 | 0.010 |
Why?
|
Time Factors | 2 | 1994 | 40063 | 0.010 |
Why?
|
Hylobates | 1 | 2000 | 13 | 0.010 |
Why?
|
Cebus | 1 | 2000 | 16 | 0.010 |
Why?
|
Neuromuscular Diseases | 1 | 1983 | 253 | 0.010 |
Why?
|
Gorilla gorilla | 1 | 2000 | 30 | 0.010 |
Why?
|
Binding Sites | 1 | 2009 | 6116 | 0.010 |
Why?
|
Extracellular Space | 1 | 1982 | 594 | 0.010 |
Why?
|
Culture Media, Serum-Free | 1 | 2000 | 158 | 0.010 |
Why?
|
Gene Deletion | 1 | 2008 | 2751 | 0.010 |
Why?
|
Risk Factors | 3 | 1992 | 72280 | 0.010 |
Why?
|
Dextrans | 1 | 1982 | 595 | 0.010 |
Why?
|
Hypothyroidism | 1 | 1985 | 659 | 0.010 |
Why?
|
Myocardium | 1 | 2013 | 4776 | 0.010 |
Why?
|
Pan troglodytes | 1 | 2000 | 229 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2008 | 6386 | 0.010 |
Why?
|
Mice, Inbred ICR | 1 | 2000 | 352 | 0.010 |
Why?
|
Chromosome Aberrations | 1 | 1986 | 1814 | 0.010 |
Why?
|
Creutzfeldt-Jakob Syndrome | 1 | 2000 | 89 | 0.010 |
Why?
|
Databases, Factual | 1 | 2014 | 7730 | 0.010 |
Why?
|
Young Adult | 2 | 2018 | 56436 | 0.010 |
Why?
|
Parathyroid Hormone | 1 | 1986 | 1801 | 0.010 |
Why?
|
Peripheral Nervous System Diseases | 1 | 1985 | 700 | 0.010 |
Why?
|
Integrins | 1 | 2003 | 846 | 0.010 |
Why?
|
Erythroid Precursor Cells | 1 | 2000 | 218 | 0.010 |
Why?
|
Genetic Variation | 2 | 1992 | 6546 | 0.010 |
Why?
|
Tumor Suppressor Proteins | 1 | 2009 | 2848 | 0.010 |
Why?
|
Macaca | 1 | 2000 | 440 | 0.010 |
Why?
|
Hypogonadism | 1 | 1985 | 798 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2018 | 57768 | 0.010 |
Why?
|
Syndrome | 1 | 1985 | 3250 | 0.010 |
Why?
|
Collagen | 1 | 2007 | 2689 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2000 | 480 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2000 | 489 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2007 | 3505 | 0.010 |
Why?
|
Colitis | 1 | 1986 | 1170 | 0.010 |
Why?
|
Glucocorticoids | 1 | 1987 | 2108 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2013 | 7908 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2007 | 5076 | 0.010 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 1992 | 3523 | 0.010 |
Why?
|
Health Services Accessibility | 1 | 2013 | 5138 | 0.010 |
Why?
|
Extracellular Matrix | 1 | 2003 | 1741 | 0.010 |
Why?
|
Hospitals | 1 | 1989 | 3952 | 0.010 |
Why?
|
Survival Rate | 1 | 2010 | 12781 | 0.010 |
Why?
|
Hepatocytes | 1 | 2002 | 1210 | 0.010 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 1999 | 627 | 0.010 |
Why?
|
Public Policy | 1 | 2000 | 572 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2010 | 5169 | 0.010 |
Why?
|
Prospective Studies | 1 | 1999 | 53280 | 0.010 |
Why?
|
Child | 2 | 2013 | 77679 | 0.010 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 1987 | 3068 | 0.010 |
Why?
|
Vascular Diseases | 1 | 1983 | 1161 | 0.010 |
Why?
|
Haplotypes | 1 | 2001 | 2781 | 0.010 |
Why?
|
Adjuvants, Immunologic | 1 | 2000 | 1001 | 0.010 |
Why?
|
Disease Progression | 1 | 2011 | 13280 | 0.010 |
Why?
|
Binding Sites, Antibody | 2 | 1986 | 349 | 0.010 |
Why?
|
Immune System | 1 | 2000 | 805 | 0.010 |
Why?
|
Cholesterol | 1 | 1983 | 2911 | 0.010 |
Why?
|
Radiotherapy, Adjuvant | 1 | 1999 | 1770 | 0.010 |
Why?
|
Costs and Cost Analysis | 1 | 2000 | 1682 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 2009 | 4935 | 0.010 |
Why?
|
Confidence Intervals | 1 | 1999 | 2970 | 0.010 |
Why?
|
Seizures | 1 | 1986 | 2859 | 0.010 |
Why?
|
Europe | 1 | 2000 | 3339 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2008 | 14726 | 0.010 |
Why?
|
Macrophages | 1 | 2007 | 5657 | 0.010 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2000 | 1581 | 0.010 |
Why?
|
Mutagenesis | 1 | 1996 | 1267 | 0.010 |
Why?
|
Interferon-gamma | 1 | 1999 | 3203 | 0.010 |
Why?
|
Exons | 1 | 1997 | 2439 | 0.010 |
Why?
|
Mastectomy | 1 | 1999 | 1793 | 0.010 |
Why?
|
Chemotherapy, Adjuvant | 1 | 1999 | 3474 | 0.010 |
Why?
|
Fetomaternal Transfusion | 1 | 1990 | 11 | 0.010 |
Why?
|
Rho(D) Immune Globulin | 1 | 1990 | 34 | 0.010 |
Why?
|
Child, Preschool | 1 | 2013 | 40992 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2002 | 3690 | 0.010 |
Why?
|
Erythroblastosis, Fetal | 1 | 1990 | 60 | 0.010 |
Why?
|
Chronic Disease | 1 | 1985 | 9147 | 0.010 |
Why?
|
Cancer Vaccines | 1 | 1996 | 1024 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 1999 | 6893 | 0.010 |
Why?
|
Immunization, Passive | 1 | 1990 | 625 | 0.000 |
Why?
|
Dose-Response Relationship, Drug | 1 | 1999 | 10949 | 0.000 |
Why?
|
Isoelectric Point | 1 | 1986 | 80 | 0.000 |
Why?
|
Labor, Obstetric | 1 | 1990 | 333 | 0.000 |
Why?
|
Chromatography, Ion Exchange | 1 | 1986 | 305 | 0.000 |
Why?
|
Survival Analysis | 1 | 1999 | 10250 | 0.000 |
Why?
|
Exchange Transfusion, Whole Blood | 1 | 1986 | 56 | 0.000 |
Why?
|
Mice, Inbred C3H | 1 | 1986 | 964 | 0.000 |
Why?
|
L-Lactate Dehydrogenase | 1 | 1986 | 424 | 0.000 |
Why?
|
Neoplasm Staging | 1 | 1999 | 11007 | 0.000 |
Why?
|
Molecular Weight | 1 | 1986 | 2255 | 0.000 |
Why?
|
Antigens, CD | 1 | 1993 | 4026 | 0.000 |
Why?
|
Cell Fusion | 1 | 1983 | 297 | 0.000 |
Why?
|
Octoxynol | 1 | 1982 | 77 | 0.000 |
Why?
|
Tetrodotoxin | 1 | 1983 | 259 | 0.000 |
Why?
|
Genotype | 1 | 1997 | 12956 | 0.000 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 1986 | 1574 | 0.000 |
Why?
|
Microbial Collagenase | 1 | 1982 | 122 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2009 | 35423 | 0.000 |
Why?
|
Cell Aggregation | 1 | 1982 | 244 | 0.000 |
Why?
|
Severity of Illness Index | 1 | 1999 | 15538 | 0.000 |
Why?
|
Osmolar Concentration | 1 | 1982 | 683 | 0.000 |
Why?
|
DNA, Single-Stranded | 1 | 1982 | 354 | 0.000 |
Why?
|
Membrane Potentials | 1 | 1983 | 1137 | 0.000 |
Why?
|
Chick Embryo | 1 | 1982 | 982 | 0.000 |
Why?
|
Microscopy, Electron, Scanning | 1 | 1982 | 964 | 0.000 |
Why?
|
Lung Neoplasms | 1 | 2003 | 13096 | 0.000 |
Why?
|
Prognosis | 1 | 1999 | 29050 | 0.000 |
Why?
|
Cricetinae | 1 | 1982 | 2472 | 0.000 |
Why?
|
Dogs | 1 | 1982 | 3913 | 0.000 |
Why?
|
Polyethylene Glycols | 1 | 1982 | 1181 | 0.000 |
Why?
|
Embryo, Mammalian | 1 | 1982 | 1701 | 0.000 |
Why?
|
Brain | 1 | 2002 | 26413 | 0.000 |
Why?
|
Age Factors | 1 | 1988 | 18367 | 0.000 |
Why?
|
Autoimmune Diseases | 1 | 1982 | 2136 | 0.000 |
Why?
|
Kidney | 1 | 1982 | 7183 | 0.000 |
Why?
|